tilation; prolonged intensive care unit stays are often required. Remarkably, at least half of reported patients with anti-NMDAR encephalitis have normal conventional brain MRI findings, and even when abnormalities are seen on MRI, they are often mild, transient, and nonspecific (2) . The diagnosis is generally made by measuring serum and CSF titers of anti-NMDAR antibodies, and treatment centers on removal of an associated tumor such as ovarian teratoma, if found, and immunomodulatory therapy such as intravenous immunoglobulin, corticosteroids, and plasmapheresis. Prognosis is good for about three-quarters of patients, who recover completely or nearly so (though often only after many months), but the remainder may be left quite disabled, and a small percentage of patients do not survive.
One of the persistent questions in our understanding of anti-NMDAR encephalitis has been the clinical-radiologic dissociation seen commonly in this disorder. The article by Finke et al. from Germany reports on a systematic imaging analysis of 24 patients with an established diagnosis of anti-NMDAR encephalitis (by antibody titers), and a cohort of age-and sex-matched controls, which they undertook to investigate structural and functional brain changes in this disorder. Using resting-state functional MRI (3), diffusion tensor imaging (4), and voxel-based morphometry (5) , as well as conventional imaging and neuropsychologic testing, the authors sought OBJECTIVE: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis with a characteristic neuropsychiatric syndrome and severe and prolonged clinical courses. In contrast, standard clinical magnetic resonance imaging (MRI) remains normal in the majority of patients. Here, we investigated structural and functional brain changes in a cohort of patients with anti-NMDAR encephalitis. METHODS: Twenty-four patients with established diagnosis of anti-NMDAR encephalitis and age-and gender-matched controls underwent neuropsychological testing and multimodal MRI, including T1w/T2w structural imaging, analysis of resting state functional connectivity, analysis of white matter using diffusion tensor imaging, and analysis of gray matter using voxel-based morphometry. RESULTS: Patients showed significantly reduced functional connectivity of the left and right hippocampus with the anterior default mode network. Connectivity of both hippocampi predicted memory performance in patients. Diffusion tensor imaging revealed extensive white matter changes, which were most prominent in the cingulum and which correlated with disease severity. In contrast, no differences in T1w/T2w structural imaging and gray matter morphology were observed between patients and controls. INTERPRETATION: Anti-NMDAR encephalitis is associated with characteristic alterations of functional connectivity and widespread changes of white matter integrity despite normal findings in routine clinical MRI. These results may help to explain the clinicoradiological paradox in anti-NMDAR encephalitis and advance the pathophysiological understanding of the disease. Correlation of imaging abnormalities with disease symptoms and severity suggests that these changes play an important role in the symptomatology of anti-NMDAR encephalitis.
Paradox Lost: Exploring the Clinical-Radiologic Dissociation Seen in Anti-NMDA Receptor Encephalitis
to establish whether there are in fact imaging signatures of this autoimmune condition that might escape detection by standard clinical MRI sequences.
Indeed, although there were no gray matter morphologic differences between patients and controls, the investigators did find a number of significant alterations of structural and functional connectivity in anti-NMDAR encephalitis patients. Specifically, patients had reduced functional connectivity between the hippocampi and the anterior default mode network. (This brain network shows functional activation when patients are not actively engaged in a cognitive task and is felt to be relevant to episodic memory, autobiographic processing, and other non-stimulus-dependent states (6) .) Of importance, the degree of hippocampal functional connectivity predicted memory performance in the anti-NMDAR patients, highlighting the clinical relevance of these specialized imaging findings. In addition, structural connectivity imaging revealed that there were quite extensive changes in white matter integrity (as measured by fractional anisotropy) in the patient group as compared with controls, particularly in the cingulum, and the degree of white matter integrity loss correlated with global disease severity, though not with specific cognitive features.
These findings serve to answer some questions regarding anti-NMDAR encephalitis (and may speak to autoimmune encephalitides more broadly as well) yet raise more questions than they answer. For example, they help us to understand that despite the normal or near-normal appearance of gray and white matter on conventional imaging in this disorder, there are important and substantial changes in connectivity in the anti-NMDAR state, both locally and globally in the brain, and these may play a critical role in the underlying pathophysiology of the disorder.
Among the questions raised by these findings, though, are the following:
1. What happens to brain structural and functional connectivity during the acute phase of this disorder? MR imaging in this study was not performed until an average of 31 months after the onset of initial symptoms (range, 9-72 months). Indeed, by the time of the imaging, some patients no longer had detectable anti-NMDAR titers.
2. What is the mechanism by which neuronal cell surface antibodies lead to widespread connectivity defects but no gray matter morphologic changes? A proposed theory of pathogenesis is that these autoantibodies cause internalization of synaptic NMDA receptors, particularly in GABAergic neurons, and thus disinhibition within brain circuits. This is a good opportunity to reflect on a broader perspective of anti-NMDAR encephalitis: Within a period of only several years, we have been introduced to and have learned much about what appears now to be one of the most common autoimmune causes of epilepsy we can currently identify (2) . Anti-NMDAR encephalitis may be more prevalent than the many other such syndromes, paraneoplastic and otherwise, that we frequently test for in unexplained cases of encephalitis, and importantly, is one that may be quite readily treatable with immunosuppressive therapy (7, 8) .
Even more, as further work emerges on the underlying molecular, cellular, and system-based pathobiologic mechanisms of seizures and cognitive/behavioral dysfunction in anti-NMDAR encephalitis, it may serve as an instructive model for our understanding of inflammatory causes of epilepsy and even for psychiatric diseases like schizophrenia, which share some of its clinical and mechanistic features.
In other organ systems, and indeed in other disorders of the nervous system, autoimmunity has turned out to be a complex, informative, and prevalent mechanism of disease. It is not surprising that this may be the case in epilepsy as well.
by Bernard S. Chang, MD
